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Abstract 
 
Introduction: An increased perception of effort and subjective fatigue are thought to be central 
to decreased exercise performance observed following disrupted sleep. However, there is limited 
understanding of the mechanisms which underpin these phenomena. We investigated the role of 
interleukin-6 (IL-6), the soluble interleukin-6 receptor (sIL-6R)) and neuroendocrine factors 
(cortisol, adrenaline, noradrenaline and brain derived neurotropic factor (BDNF)) in mediating 
these responses at rest and during exercise. Methods: In a randomized order ten healthy active 
males completed 3 experimental trials following different sleep conditions; a single night of 
sleep deprivation (DEP), partial sleep deprivation equivalent to 4-hrs of sleep (PART) and 
normal sleep (CON). The experimental sessions consisted of physiological and perceptual 
measurements of exercise intensity throughout 45-min moderate intensity and 15-min maximal 
effort cycling. Cytokine and neuroendocrine factors were assessed at rest and in response to 
exercise. Results: Sleep deprivation resulted in increased resting IL-6, lower blood glucose, 
increased perceived fatigue and perception of effort, lower free-living energy expenditure, and 
reduced maximal exercise performance. In contrast, sleep deprivation did not alter physiological, 
cytokine or neuroendocrine responses to exercise. Variations in the resting concentration of IL-6 
were associated with lowered blood glucose, an increased perception of effort, and impaired 
exercise performance. Resting concentrations of cortisol, adrenaline, noradrenaline, and BNDF 
showed subtle interactions with specific aspects of mood status, and performance but were not 
impacted by sleep deprivation. There were minimal effects of partial sleep deprivation. 
Conclusions: These findings demonstrate that cytokine and neuroendocrine responses to 
exercise are not altered by sleep deprivation but that changes in the resting concentration of IL-6 
may play a role in altered perception of effort in this context. 
 
Key Words: Sleep deprivation; fatigue; mood; exercise; BDNF; IL-6  
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1. Introduction 
It is widely recognised that poor sleep can have a negative impact upon a wide array of 
psychological and physiological functions (1). Numerous studies have also investigated the 
impact of acute sleep deprivation on physical performance, and while there is a broad consensus 
that physiological responses to exercise remain largely unchanged, an elevation in rate of 
perceived exertion (RPE) is thought be a crucial factor mediating impaired exercise performance 
(2). Interestingly, there is evidence that increased perception of task difficulty is a major factor in 
impaired performance of not only physical (3) but also cognitive tasks (4), and yet the 
underpinning biological mechanisms involved in these phenomena remain poorly understood. 
An improved understanding of the mechanisms involved in these processes may lead to 
improved management of or countermeasures to the negative effects of poor sleep. 
 
There is a growing interest in the role of cytokines and neuroendocrine signalling factors (e.g. 
cortisol, adrenaline, noradrenaline and brain derived neurotropic factor (BDNF)) and their 
relationship to changes in mood and sensation of fatigue (5). Mechanistic studies are often 
difficult in humans, yet there is good evidence that at least some of these signalling factors can 
readily cross the blood brain barrier and that even a small change in the circulating concentration 
can have signalling effects within the brain (6). Indeed, recent evidence suggests that the 
circulating concentration of BDNF is positively related to mood and cognition (7), while a 
negative relationship has been observed between IL-6 and mood (8). This is particularly 
important given that impaired mood status and wellbeing are some of the most consistently 
reported psychological effects of sleep deprivation (9,10), and it is plausible that impairments in 
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athletic performance may be mediated in part by alterations in mood brought about by changes in 
cytokine or neuroendocrine signalling. 
 
Recent evidence has also documented a relationship between IL-6 and BDNF following 
disrupted sleep (11,12). Reports of lower circulating concentrations of BDNF are primarily from 
epidemiological studies and could therefore be confounded by other factors (e.g. diet or levels of 
physical activity) (11). Previous well conducted studies have shown that sleep deprivation can 
cause an elevation in IL-6 in response to acute sleep deprivation (12), however, there is limited 
study of sIL-6R in this context. The effects of IL-6 on the brain likely extend beyond mood and 
may impact upon the sensation of fatigue which could have important consequences for exercise 
performance (13). This may be important considering that recent evidence suggests that some of 
the fatigue inducing effects of IL-6 may be related to ‘trans-signalling’ through sIL-6R (14).  
 
Our group recently provided novel evidence that aspects of interleukin-6 ‘trans-signalling’ 
through the soluble IL-6 receptor (sIL-6R) was related to measures of sleep, mood and 
perception of fatigue in elite athletes during a prolonged training period (15). However, this 
study only examined resting measures and was limited in terms of the breadth of the analysis.  In 
fact, the majority of studies have focussed on resting concentrations of cytokine and 
neuroendocrine responses following sleep deprivation, while there is considerably less research 
assessing partial sleep deprivation which may be more similar what is experienced in the real 
world. Further to this very few studies have investigated any potential divergent responses to 
exercise. Therefore, the aim of the current study was to (a) characterise the effects of partial and 
complete sleep deprivation on selected cytokine and neuroendocrine responses both at rest and in 
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response to exercise and (b) to investigate their relationship with subjective fatigue and effort 
perception. 
 
2. Methods 
Prior to commencement of the study the University Health Sciences Research Ethics Committee 
granted ethical approval (project code SH16170020-R) for all methods and ensured that the 
study conformed to the declaration of Helsinki. All participants gave written informed consent to 
participate in the study. 
 
2.1. Participants 
Participants comprised of ten recreationally active males. Their age, height, weight and VO2max 
were as follows (mean ± SD): 27 ± 6 years, 182 ± 8 cm, 88 ± 8 kg, 43 ± 7 ml.kg.min
-1
. As part of 
the screening procedures participants completed in departmental health screening and physical 
activity questionnaires and the Pittsburgh Sleep Quality Index (PSQI) (16). In order to take part 
in the study, participants needed to declare themselves free from injury and illness for a 
minimum of 2 weeks prior to commencement of the study and be identified as having normal 
sleep pattern based upon a Global PSQI score <5 (16). Participants were required to not be 
taking any medication known to interfere with normal inflammatory responses (e.g. NSAIDs 
etc).   
 
2.2. Study design 
This study comprised a randomised, repeated measures crossover design. Participants completed 
preliminary testing in order to ascertain a measurement of aerobic fitness (VO2max) and were 
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provided with an actigraph, (Actiheart, Version 2.2, CamNTech Ltd., Cambridge, UK) which 
was worn throughout the study and used to assess sleep and activity patterns throughout the 
study. Energy expenditure was calculated for the 24-hr period before each test session, the 12-hrs 
on the same day of each test session and in the 24-hr period the day following each test in order 
to assess activity patterns before and after each condition. In these conditions energy expenditure 
was measured using an actiheart which integrates accelerometer and heart rate (17). 
 
Participants also completed a sleep diary, estimating the quality of their sleep on a 5-point scale, 
and the time at which they went to sleep and awoke the day prior to each test session. Following 
at least 3 days rest, participants completed 3 further experimental trials with manipulated sleep 
routines in a randomised and counterbalanced order with a further 7 days between each 
subsequent experimental trial. In order to account for the known effects of time of day on 
hypothalamic pituitary adrenal (HPA) axis, sympathetic nervous system (SNS), mood and 
inflammatory signalling, experimental test sessions were completed at the same time of day on 
each occasion (between 7:00-9:00am). The experimental trials consisted of a control condition 
(CON), partial sleep deprivation (PART) and a night of no sleep (DEP) which was equivalent to 
24-hrs of sleep deprivation. Prior to CON, participants obtained a normal nights sleep (7-9 hrs) 
in their own bed. For PART and DEP, participants arrived at the laboratory the evening prior to 
testing and remained under the supervision of the researchers until testing was completed the 
following day. For PART, participants were allowed a 4-hr sleep opportunity in a prepared 
bedroom, commencing at their normal bedtime and were then awoken 4-hr later. Once awake, 
participants remained under the supervision of the researchers at all times, in order to ensure that 
participants remained awake throughout the trial. Participants carried out sedentary activities 
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such as, watching films, reading and talking to the researchers. Throughout this period 
participants were permitted to drink water ad libitum, but were instructed to abstain from food 
for 12-hrs prior to the commencement of each test session and to replicate their diet in between 
conditions.  
 
During each experimental trial (detailed below) participants initially completed questionnaires 
for the assessments of mood states and a sleep diary. Following a brief rest, participants then 
completed an aerobic exercise bout comprising 45-min of standardised submaximal exercise, 
immediately followed by 15-min self-paced maximal effort time-trial where participants were 
encouraged to cycle as far as possible. Blood samples were taken at rest, at the end of the 
submaximal exercise, immediately following the completion of maximal exercise and following 
30 minutes of recovery. Blood samples were then later used for the assessment of circulating 
concentrations of specific cytokines and immune-endocrine markers. A schematic representation 
of the experimental testing is provided in figure 1. 
 
xxx Insert Figure 1 here xxx 
 
2.3. Preliminary Testing 
Participants completed an incremental exercise test on an electromagnetically braked cycle 
ergometer (Lode Excalibur, Groningen, Netherlands). Expired gases were continuously 
measured using an online gas analysis system (Cortex Biophysik Metalyzer, Germany), while 
heart rate (HR) was measured via a short-range telemetric HR monitor (RS400, Polar Electro, 
Finland). The protocol consisted of 3-min stages, starting at 100W and increased incrementally 
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by 30W each stage, until volitional exhaustion. Participants were instructed to maintain a pedal 
cadence of 80 rpm throughout the test. Maximal oxygen uptake (VO2max) was recorded as the 
highest 30-s period of oxygen consumption. Oxygen consumption values obtained throughout 
each participant’s test were used to plot a linear regression of power output versus oxygen 
consumption and the resultant equation was then used to determine standardised power outputs 
for subsequent test sessions. Following the maximal test participants were then familiarised with 
tests to be conducted in subsequent sessions. 
 
2.4. Experimental procedures 
2.4.1. Subjective fatigue and mood states 
Participants completed a modified and shortened version of the profile of mood states (POMS) 
questionnaire (18) to assess their subjective level of fatigue and mood status. Participants scored 
themselves on a 1-5 scale in the following categories: tense, miserable, angry, lively fatigued and 
confused. Prior to completing the questionnaire, participants were provided with a full 
explanation of each question. Questionnaires of this type have been shown to be reliable and 
valid for assessing fatigue in sporting contexts (19). 
 
2.4.2. Aerobic exercise session 
The aerobic exercise session consisted of a 45-min of submaximal cycling at a constant power 
output equivalent to 60% of the individuals VO2max. This was immediately proceeded by a 15-
min maximal effort self-paced time-trial, whereby participants were instructed to cycle as far as 
possible in the given time. This allowed for the comparison of physiological and biochemical 
responses to both standardised submaximal exercise and maximal exercise within the same 
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experimental protocol. Distance travelled was calculated and expressed as a percentage of the 
distance that individual achieved in the control condition. Respiratory gases and HR were 
measured continuously throughout each trial and expressed as a percentage of individual’s 
maximum value measured during the maximal incremental test. Every 5-min RPE (20), blood 
lactate and glucose were measured. Lactate and glucose were measured using an automated 
benchtop analyser (Biosen C-Line Clinic, EKF-diagnostic GmbH, Barleben, Germany) from 
capillary blood samples, obtained in the final 30-s of each 5-minperiod. 
 
2.5. Blood collection and analysis 
A cannula (Becton, Dickson & Company, Oxford, UK) was inserted into the antecubital vein of 
the arm. Whole blood (10 mL per time point) samples were collected into K3EDTA vacutainers 
(Greiner Bio-one; Frickenhausen, Germany) at rest (PRE), in the final 3-minof the submaximal 
portion of the exercise trial (DUR), at cessation of the maximal exercise (POST) and 30-min into 
recovery (30 MIN). Samples were then centrifuged at 4 °C, 3000 g for 10-min and the resultant 
plasma was separated into aliquots and stored at −80 °C, until subsequent analysis. 
Commercially available ELISA kits (Biotechne, Abingdon, UK) were used to quantify the 
concentration of IL-6, sIL-6R, cortisol, BDF, adrenaline and noradrenaline. All samples were 
analysed in duplicate and the manufacturer’s instructions were adhered to at all times. In order to 
produce concentrations that were within the dynamic range of each assay, plasma samples were 
diluted with a commercially available diluent (DY997, R&D Systems Ltd) prior to analysis of 
sIL-6R (1:100), cortisol, BDNF, adrenaline and noradrenaline (all 1:20). To minimise variation 
between assays, all samples from an individual participant were analysed in the same assay. In 
our hands the intra-assay coefficient of variation (CV) for these assays were as follows: IL-6- 4.1 
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± 2.6%, sIL-6R- 2.1 ± 1.8%, cortisol- 6.4 ± 4.7%, BDNF- 3.2 ± 2.2%, adrenaline-4.0 ± 2.5% and 
noradrenaline- 4.0 ± 4.1%. The concentration of each analyte was determined in relation to a 4-
parameter standard curve (GraphPad Prism, San Diego, Calif., USA) and were corrected for 
changes in plasma volume based upon established criteria (21). 
 
 
2.6. Statistical Analysis 
The Shapiro Wilk test was used to test for normality in scale data. For resting and summary data, 
one-way repeated measures ANOVAs or non-parametric Friedman test were used where 
appropriate. A two-way repeated measures ANOVA (sleep condition x time) was used to assess 
the effect of sleep condition on the exercise induced responses for IL-6, sIL-6R, cortisol, BDNF, 
adrenaline and noradrenaline. When data was non-normally distributed, log-transformations 
were performed prior to analysis and the respective data was then back transformed for ease of 
presentation in figures. When main effects were identified, post-hoc analysis was performed 
using simple pairwise comparisons with Bonferroni adjustment or Dunn’s test where appropriate. 
Pearson correlation and Spearman rank were used to assess the relationship between parametric 
and non-parametric data respectively. Effect sizes for main effects are presented as eta
2 (η2). 
Statistical analyses were undertaken using GraphPad Prism and SPSS (IBM SPSS Statistics for 
Windows, Version 25.0. Armonk, NY: IBM Corp.). All data are presented as mean ± standard 
deviation unless otherwise stated and statistical significance was set at p<0.05. 
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3. Results 
3.1. Sleep and energy expenditure 
Participants reported sleeping significantly more (467 ± 42 min) for CON than PART (217.5 ± 
21 min) and DEP (0 ± 0) respectively (F=674.9, P<0.001, η2= 0.98), with participants falling 
asleep later prior to PART than CON (P=0.039, mean difference 19 min, 95% CI 0.9 to -38 min). 
Sleep quality was significantly better for CON (3.3 ± 0.8) than PART (2.6 0 ± 0.7) and DEP (0 ± 
0) (F=98.35, P<0.001, η2= 0.92). There was no significant difference in total energy expenditure 
in the 24-hrs before the test (CON= 2533 Kcal vs PART= 2542 Kcal vs CON 2761, P>0.05). 
Energy expenditure in the 12-hrs following the experimental trials showed a main effect of 
condition (F=5.2, P=0.018, η2= 0.39), and was significantly lower in DEP than CON (mean 
differences -208 Kcal, 95% CI (CI) -404 to -13 Kcal) and PART (mean difference -200 Kcal, -
396 to -5 Kcal). But were not significantly different in the 24-hr period the day following each 
trial (CON= 2681 ± 361 Kcal, PART= 2697 ± 514 Kcal, DEP= 2547 Kcal). 
 
3.2. Resting measurements 
The results of subjective fatigue and mood status following each of the sleep conditions are 
summarized in Table 1. Participants reported being significantly more miserable (P=0.006) and 
confused (P=0.019) following DEP than CON, while also feeling less lively (P=0.019). 
Participants reported being significantly more fatigued following PART and DEP than CON 
(P=0.001). 
 
xxx Insert Table 1 here xxx 
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There were no significant differences in the resting concentration of sIL-6R, cortisol, BDNF, 
adrenaline or noradrenaline between CON, PART and DEP. There was a significant effect of 
condition on resting IL-6 (F=5.6, P=0.012, η2= 0.39), and blood glucose (F=4.2, P=0.032, η2= 
0.31) (Fig 2A and 2B respectively). Post-hoc testing revealed significantly higher IL-6 following 
DEP (0.95 ± 0.37 pg/ml) Vs CON (0.62 ± 0.22 pg/ml), mean difference -0.33 pg/ml (95% CI -
0.59 – 0.06 pg/ml), and a significant decrease in blood glucose (DEP: 4.2 ± 0.3 Vs CON: 4.6 ± 
0.5 mmol/L, mean difference 0.44 mmol/L,95% CI 0.01 – 0.88 mmol/L). Correlation analysis 
revealed a significant negative relationship between resting IL-6 and blood glucose (P=0.02, r=-
0.44, 95% CI -0.7 to -0.07) (See figure 2 for a summary). Subjective fatigue at rest was 
negatively correlated to the total energy expenditure in the 12-hrs following the exercise 
(P=0.01, r=-0.46, 95% CI -0.75 to -0.04). Resting concentrations of IL-6 and sIL-6R were 
negatively related (P=0.01, r=-0.48, 95% CI -0.72 to -0.12). Adrenaline was negatively related to 
subjective perception of fatigue at rest (P=0.027, r=-0.43, 95% CI -0.7 to -0.06), while 
noradrenaline was positively related to perceived ‘tension’ (P=0.027, r=0.49, 95% CI 0.07 to 
0.77). BDNF was negatively related to perceived rating of ‘miserableness’ (P=0.02, r=-0.46, 
95% CI -0.72 to -0.09), and positively related to perceived ‘liveliness’ (P=0.025, r=0.44, 95% CI 
0.06 to 0.71). 
 
xxx Insert Figure 2 here xxx 
 
3.3. Physiological and perceptual responses to exercise 
Physiological and perceptual responses to exercise are summarised in table 2, while figure 3 
provides a graphical demonstration of the differences between key physiological and perceptual 
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responses to the different sleep conditions. There were no significant differences between any of 
the physiological responses (mean VO2, HR, respiratory exchange ratio (RER) or lactate) 
between the three experimental conditions during the 45-min constant load portion of the 
exercise, while perception of effort (as measured by mean RPE) was significantly higher in DEP 
(13.4 ± 1.9) than CON (11.8 ± 1.6) (P=0.03). 
 
Physiological responses to maximal exercise were significantly different between CON and 
DEP. There was a main effect of condition on mean VO2 (F=3.3, P=0.038, η
2
= 0.3), which was 
significantly higher following CON (85.4 ± 5.5%) than DEP (78.5 ± 11.4%), mean difference 
7.7% (95% CI 0.3 - 14.9%). Similarly, there was a main effect of condition on distance travelled 
(F=4.1, P=0.026, η2= 0.23), with significantly less distance travelled in DEP than CON (mean 
difference 11.4%, 95% CI 1.2 to 21.6 %) (Fig 3C). Mean RPE during submaximal exercise was 
positively related to subjective fatigue at rest (P<0.001, r=0.63, 95% CI 0.33 - 0.81) and 
negatively related to the mean VO2 achieved during the maximal exercise (P=0.03, r=-0.39, 95% 
CI -0.66 to -0.04), and distance travelled (P=0.006, r=-0.49, 95% CI -0.72 to -0.16). Subjective 
fatigue at rest was negatively related to mean VO2 (P=0.003, r=-0.56, 95% CI -0.77 to -0.22) and 
the distance travelled during maximal exercise (P<0.001, r=-0.7, 95% CI -0.86 to -0.44). In 
contrast, distance travelled during maximal exercise was positively related to feeling of 
‘liveliness’ at rest (P<0.001, r=0.66, 95% CI 0.37 - 0.83). 
 
There was a main effect of condition on mean HR (F=5.0, P=0.014, η2= 0.27), which was 
significantly higher following CON (93.2 ± 2.2%) than DEP (87.7 ± 6.1%), mean difference 
5.4% (95% CI 0.9 – 9.8%). There was a main effect of condition on mean RER (F=6.1, P=0.009, 
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η2= 0.4), which was significantly higher following CON (85.4 ± 5.5%) than DEP (78.5 ± 
11.4%), mean difference 7.7% (95% CI 0.3 - 14.9%). There was a main effect of condition on 
mean blood lactate (F=3.8, P=0.039, η2= 0.3), which was significantly higher following CON 
(5.4 ± 0.7 mmol/L) than DEP (4.3 ± 1.5 mmol/L), mean difference 1.1 mmol/L (95% CI 0.05 - 
2.1 mmol/L). In contrast to submaximal exercise, there was no effect of condition on mean RPE 
during the maximal exercise. 
 
xxx Insert Table 2 here xxx 
 
xxx Insert Figure 3 here xxx 
 
3.4. Cytokine and neuroendocrine responses to exercise 
Exercise induced changes in plasma concentration of IL-6, sIL-6R, adrenaline, noradrenaline, 
cortisol and BDNF are reported in Figure 4.  For IL-6 there was a main effect of time (F=84.1, 
P<0.0001, η2= 0.9), but no effect of condition (F=1.2, P=0.3, η2= 0.05) (Fig. 4A). IL-6 was 
significantly elevated immediately following the constant load portion of all exercise trials 
(P=0.027, mean difference 0.17 pg/ml, 95% CI 0.018 - 0.32 pg/ml), continued to increase 
following the time trial (P<0.0001, mean difference 0.40 pg/ml, 95% CI 0.032 - 0.49 pg/ml), and 
remained elevated 30-min after cessation of the exercise. IL-6 concentration at rest was 
positively correlated with the mean RPE during the constant load portion of the exercise (P=0.03, 
r=0.4, 95% CI 0.04 - 0.67), but was negatively related to the mean VO2 achieved during maximal 
exercise (P=0.029, r=-041, 95% CI -0.67 to -0.05) and distance travelled during maximal 
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exercise (P=0.035, r=-0.39, 95% CI -0.66 to -0.01). In contrast distance cycled was positively 
related to post exercise adrenaline concentration (P=0.038, r=0.39, 95% CI 0.023 - 0.66). 
 
 The change in IL-6 from CON accounted for 25% of the variance in the mean VO2 achieved 
during maximal exercise and 22% of the distance cycled. sIL-6R showed a main effect of time 
(F=5.8, P=0.005, η2= 0.46), with no main effect of condition (F=1.6, P=0.23, η2= 0.19). There 
was a trend for elevated sIL-6R following the time-trial and 30-min into recovery, however 
neither reached statistical significance (P=0.11 and P=0.08 respectively) (Fig 4B). sIL-6R 
concentration at rest was negatively correlated with the mean RPE during the constant load 
portion of the exercise (P=0.009, r=-0.49, 95% CI -0.73 to -0.14). Adrenaline showed a 
significant main effect of time (F=14.9, P<0.0001, η2= 0.15), with no main effect of condition 
(F=0.4, P=0.67, η2= 0.03) (Fig.4C). Adrenaline was significantly increased at each time point 
compared to rest, peaking immediately post the time-trial (P=0.001, mean difference 0.72 ng/ml, 
95% CI 0.4 - 1.0 ng/ml). Noradrenaline showed a significant main effect of time (F=30.7, 
P<0.0001, η2= 0.39), with no main effect of condition (F=0.6, P=0.5, η2= 0.01) (Fig 4D). Post-
hoc tests revealed noradrenaline was increased from rest at each time point, peaking immediately 
post time-trial (P<0.0001, mean difference 2.2 ng/ml, 95% CI 1.5 - 2.8 ng/ml). The resting 
concentration of noradrenaline was negatively correlated with the mean RPE during the constant 
load portion of the exercise (P=0.04, r=-0.46, 95% CI -0.75 to -0.02). BDNF showed a 
significant main effect of time (F=23.2, P<0.0001, η2= 0.22), with no effect of condition 
(F=0.02, P=0.98, η2= 0.008). BDNF was significantly elevated at each time point post exercise, 
peaking immediately post time-trial (P=0.002, mean difference 3090 pg/ml, 95% CI 1210 - 4970 
pg/ml). Cortisol displayed significant main effects of time (F=6.2, P=0.002, η2= 0.41) and 
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condition (F=3.8, P=0.04, η2= 0.29) (Fig 4E). However, following a correction for multiple 
comparisons there were no clear patterns to the variation of the data. Cortisol concentration at 
rest was positively correlated with the mean RPE during the constant load portion of the exercise 
(P=0.002, r=0.56, 95% CI 0.24 - 0.77). 
 
xxx Insert Figure 4 here xxx 
 
4. Discussion 
This study investigated the role of selected cytokine and neuroendocrine factors in altered  
physiological and perceptual responses to exercise following partial and complete sleep 
deprivation. A single night of sleep deprivation led to an increased perception of fatigue, 
impaired maximal exercise performance, decreased blood glucose, elevated IL-6 at rest and a 
reduction in physical activity in the 12-hrs after sleep deprivation. This increase in IL-6 may be 
mediated in part by altered glucose homeostasis. Neither partial nor complete sleep deprivation 
altered cytokine or neuroendocrine responses to exercise. However, perception of effort was 
significantly increased following 24-hrs of sleep deprivation, which was also associated with 
variations in the resting plasma concentrations of IL-6, sIL-6R, cortisol and noradrenaline. 
Maximal exercise performance was impaired, likely through an increased perception of effort, 
which may be mediated in part by an increase in resting IL-6 concentration (Fig 2A). With the 
exception of subjective fatigue and resting blood glucose, partial sleep deprivation had minimal 
effects on the responses measured in the current study, however, these findings should not be 
extrapolated to scenarios of chronic partial sleep deprivation. Taken together these findings 
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provide novel insights into the mechanisms that may contribute to an increased perception of 
effort and ultimately impaired exercise performance following sleep deprivation. 
 
In accordance with previous studies, we have demonstrated that perception of effort, but not 
physiological responses to intensity matched submaximal exercise, were affected by sleep 
deprivation; and that subsequent maximal aerobic exercise performance was impaired and 
coincided with significantly lower physiological responses (see Fig 3A) (3,22,23). These 
responses were also preceded by disruptions in mood and particularly subjective perception of 
fatigue (Table 1), which have routinely been observed in the context of impaired sleep (9). 
Interestingly, subjective fatigue prior to exercise and percepetion of effort during the 
submaximal exercise were both related to the mean VO2 and distance cycled during maximal 
exercise, provinding further evidence of their importance in exercise performance. Importantly, 
sleep deprivation induced elevations in IL-6 were associated with an increased perception of 
effort during exercise and exercise performance and the mean VO2 achieved during maximal 
exercise. Perhaps the most convincing evidence from the current study is that 22% of the 
variance in performance between conditions was accounted for by the change in resting IL-6 
between conditions. Notably, when we examined the IL-6 response to exercise there was no 
relationship to performance or the detrimental effects of sleep deprivation, this appears to be yet 
another example of the subtle and context dependent nature of IL-6 signalling. This is a 
signficant result given the highly complex and multifactoral nature of exercise performance. As 
such, it appears that IL-6 may play a role in impaired exercise performance following sleep 
deprivation, potentially mediated via an increased perception of effort. Previous studies have 
shown that sleep deprivation induced increases in IL-6 are associated with an increased 
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perception of pain (24). Given the link between perception of effort and pain perception, it is 
highly plausible that the two phenomena may be linked or interact. It is feasible that perceived 
effort is increased in part by the pain sensitizing effect of IL-6, however this is somewhat 
speculative and further work is required to investigate the potentially subtle role of IL-6 in 
mediating these responses. Further to this, we demonstrated that resting blood glucose was 
lowered following both partial and complete sleep deprivation (Fig 2B), which was positively 
related to the increase in IL-6 (Fig 2C). Given the established role of IL-6 in glucose metabolism 
(25), it is highy plausible that alterations in glucose metabolism are partly responsible for the 
increase in IL-6. The source of the increased plasma IL-6 following sleep deprivation remains 
poorly understood, however, it is feasible that skeletal muscle may be the source of additional 
IL-6 in this context given that IL-6 production by skeletal muscle is influenced by muscle 
glycogen content (26), which has been shown to be reduced following sleep deprivation (27). 
 
With the exception of the aforementioned results for IL-6, the effects of sleep deprivation on sIL-
6R and neuroendocrine factors measured in the current study were minimal. Contrary to findings 
from a recent epidemiological study (11), we found that the plasma concentration of BDNF was 
not reduced following sleep deprivation, but that lower concentrations of BDNF were related to 
negative changes in mood. As such, it is possible that sleep deprivation per se is not the direct 
cause of reduced BDNF reported in insomnia suffers or those with impaired sleep, and it is more 
likely that the accumulated psychological stress associated with insomnia results in decreased 
BDNF (7). Sleep deprivation had no discernible impact on sIL-6R, and this finding is interesting 
considering the extremely limited and somewhat conflicting available evidence regarding the 
impact of sleep on sIL-6R. Dimitrov and colleagues (28) previously reported that sleep 
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deprivation abolished the sleep induced increase in sIL-6R, while in a longitudinal setting our 
group previously reported that sIL-6R was positively related to subjectively reported sleep 
quality (15). Interestingly, recent evidence suggests that the relationship may be bi-directional in 
that sleep can also be impacted by IL-6 trans-signalling through sIL-6R mediated responses 
within the brain (29); this complex interaction warrants further research in those with chronic 
sleep conditions. 
 
We found a main effect of sleep condition on plasma cortisol which accounted for 29% of the 
variance in the resting values, with cortisol appearing higher following both partial and complete 
sleep deprivation (Fig. 4E), however post hoc comparisons were not statistically significant. This 
appears somewhat reflective of previous studies as the effect of sleep deprivation on cortisol 
remain largely unclear, with studies having reported no effect (30), increased (31) and decreased 
(32) plasma cortisol concentration. However, in the current study we observed a positive 
relationship between resting cortisol concentration and RPE (r=0.56), which is very similar to the 
correlation reported (r=0.551) in a previous longitudinal study which assessed the relationship 
between cortisol and session RPE (33). As such, cortisol responses to sleep deprivation remain 
unclear, but our results further emphasise the role of cortisol in effort perception. 
 
Similarly, we found no effect of sleep condition on the resting concentration of adrenaline or 
noradrenaline, which does appear in accordance with the apparent consensus (34). However, 
resting adrenaline concentration was negatively related to perception of fatigue at rest while post 
exercise adrenaline concentration was positively related to exercise performance. These findings 
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would appear in line with the established role of adrenaline in facilitating physical activity, but 
highlight the importance subjective fatigue in this relationship. 
 
Similarly to IL-6, resting cortisol concentration was positively correlated to perception of effort 
during exercise. Taken together, it may be that while adrenaline, noradrenaline and cortisol are 
not impacted by sleep deprivation per se, they do play a role in alterations of mood and effort 
perception during exercise. Further than this, it appears that differences in exercise induced 
adrenaline concentration also account for some variation in performance.  This is important when 
considering recent evidence that individual differences in anxiety and psychological stress play a 
role in immune responses to exercise (35). Any interactions between sleep, mood and immune-
endocrine responses are likely to be complex and interdependent and future studies should be 
carefully designed in order to examine potential interactions and investigate the direction of 
effects. 
 
It is well documented that sleep and physical activity share a bi-directional relationship (36) and 
can also be involved in development of chronic health conditions such as diabetes or obesity 
(37). In this regard, we found that free-living energy expenditure was reduced in the 12-hrs after 
sleep deprivation and was negatively related to the level subjective fatigue reported by 
participants in the morning prior to exercise. It may be that an increased perception of fatigue, as 
a result of impaired sleep, may make exercise a less attractive prospect, therefore resulting in 
reduced levels of physical activity. If repeated this could have important negative consequences 
for long term health. However, it is important to stress that the current study examined responses 
to single night sleep deprivation and while this is similar to the quantity of sleep occasionally 
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experienced by athletes prior to competition (2) or the sleep deprivation experienced by night 
shift workers (38), it is not necessarily representative of more prolonged sleep deprivation or 
chronic partial sleep deprivation. Given the increased prevalence of sleep deprivation and 
physical inactivity in modern society, this is an important finding and highlights the importance 
of subjective fatigue in the context of physical activity. Physical activity levels were not 
significantly different in the 24 hr period the day after the trial, suggesting that physical activity 
levels return to normal following one complete sleep cycle. As such, it is important to emphasise 
that the current study focused specifically on acute sleep disturbance and that these findings 
should not be extrapolated to circumstances of chronic partial sleep deprivation, which may 
indeed be a more common scenario. In this regard, future studies are required to further 
investigate chronic partial sleep loss. 
 
In the current study, exercise induced changes in cytokine and neuroendocrine factors were 
largely maintained following partial and complete sleep deprivation. This is important 
considering that exercise induced changes in IL-6 and BDNF (amongst a range of other factors) 
appear important for exercise induced adaptations in insulin sensitivity, lipolysis (39,40) and 
improved cognition and mood status (41). Further to this, there is evidence from animal studies 
that chronic exercise training can negate the increase in circulating IL-6, which is induced by 
sleep deprivation (42), suggesting that exercise training may in fact prevent some of the negative 
effects of sleep deprivation via anti-inflammatory mechanisms. It is also possible that exercise 
induced elevations in BDNF, may help to mitigate some of the deleterious effects that sleep 
deprivation can have on mood status and perceived wellbeing. It is important to emphasise that 
the effects observed in our study are likely multifactorial and highly complex, and as such, there 
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are undoubtedly a wide range of additional signalling factors which may also contribute to the 
observed responses. In this regard, we encourage further study in order to further explain 
variations in perceived fatigue and mood disturbance, as a better mechanistic understanding may 
well lead to improved management of or countermeasures to sleep deprivation. 
 
In conclusion, the current study shows elevated circulating concentrations of IL-6 at rest appear 
to play a role in the well-established impairments in mood, perception of effort and exercise 
performance experienced following sleep deprivation. In contrast, cortisol, adrenaline, 
noradrenaline and BDNF were not impacted by sleep deprivation but do appear to account for 
subtle variations in mood and effort perception. Neither partial nor 24-hrs of sleep deprivation 
impact the cytokine and neuroendocrine responses to exercise measured in this study. Further to 
this, we found that free-living energy expenditure was reduced following 24-hrs of sleep 
deprivation and that the level of subjective fatigue at rest explained a significant proportion of 
the variance. Taken together, these findings highlight the importance of IL-6 in the perception of 
effort and fatigue, which is an important finding given the increasing prevalence of sleep 
deprivation and physical inactivity in modern society. 
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Figure Legends 
 
Figure 1. A schematic representation of the experimental trial. 
 
Figure 2. Resting concentration of IL-6 (A) and blood glucose (B) following three different 
sleep conditions Sleep conditions comprised normal night of 7-9-hrs sleep (CON), to a 4-hr sleep 
opportunity at the start of the night (PART) and a single night of sleep deprivation (DEP). 
Correlation between resting IL-6 and blood glucose (C). *= significantly different to CON. 
 
Figure 3. The mean oxygen uptake (A) and perception of effort (B) during 45-minsubmaximal 
constant load cycling exercise and a 15-min self-paced maximal effort time-trial following three 
experimental sleep conditions. Figure (C) depicts the distance travelled in the 15-min self-paced 
maximal effort time-trial (relative to the distance each person travelled in the control condition).  
*= a significant difference between CON and DEP. VO2, oxygen uptake; RPE, rating of 
perceived exertion. 
 
Figure 4. Plasma IL-6 (A), sIL-6R (B), adrenaline (C), noradrenaline (D), cortisol (E) and 
BDNF (F) responses to exercise following three different sleep conditions.  
a=significantly different to PRE 
b= significantly different to DUR 
c= significantly different to POST 
d= significantly different to 30 MIN 
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Table 1. Comparisons of fatigue and mood state following the three different sleep conditions. 
Sleep conditions comprised normal night of 7-9-hrs sleep (CON), to a 4-hr sleep opportunity at 
the start of the night (PART) and a single night of sleep deprivation (DEP).  
 
 CON PART DEP 
Tense 0.7 ± 0.7 1.1 ± 0.9 1.1 ± 0.9 
Miserable 0.0 ± 0.0 0.2 ± 0.4 1.1 ± 1.3* 
Angry 0.0 ± 0.0 0.0 ± 0.0 0.2 ± 0.6 
Lively 1.9 ± 1.0 1.5 ± 0.7 0.6 ± 0.8* 
Fatigued 0.7 ± 0.5 2.0 ± 0.7* 2.7 ± 1.5* 
Confused 0.1 ± 0.3 0.5 ± 0.7 1.3 ± 1.6* 
 
*= Significantly different to Control (P<0.05) 
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Table 2. Summary of physiological and perceptual responses to 45-minute submaximal constant 
load cycling exercise and a 15-min self-paced maximal effort time-trial following three separate 
sleep conditions.  
 
Submaximal Exercise CON PART DEP 
Mean VO2 (%Max) 62.5 ± 5.8 61.8 ± 5.7 61.1 ± 4.4 
Mean HR (%Max) 73.9 ± 3.8 73.9 ± 3.8 72.5 ± 4.3 
Mean RER 0.89 ± 0.03 0.88 ± 0.04 0.87 ± 0.03 
Mean Lactate (mmol/L) 2.0 ± 0.7 1.9 ± 0.7 1.8 ± 0.6 
Mean RPE (A/U) 11.8 ± 1.6 12.6 ± 0.9 13.4 ± 1.9* 
        
Maximal Exercise       
Mean VO2 (%Max) 85.4 ± 6.5 83.4 ± 6.2 78.5 ± 11.4* 
Mean HR (%Max) 93.2 ± 2.2 91.5 ± 1.8 87.7 ± 6.1* 
Mean RER 0.96 ± 0.02 0.95 ± 0.03 0.92 ± 0.05* 
Mean Lactate (mmol/L) 5.4 ± 0.7 4.9 ± 1.1 4.3 ± 1.5* 
Mean RPE (A/U) 18.1 ± 1.3 17.9 ± 0.9 18.5 ± 1.1 
 
*= Significantly different to Control (P<0.05) 
VO2, oxygen uptake; HR, heart rate; RER, respiratory exchange ratio; RPE, rating of perceived 
exertion. 
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